Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator

Int J Cancer. 1997 Nov 27;73(5):740-8. doi: 10.1002/(sici)1097-0215(19971127)73:5<740::aid-ijc22>3.0.co;2-8.

Abstract

Al-trans retinoic acid (RA) enhanced human, S-type, SK-N-SH neuroblastoma cell invasion of reconstituted basement membrane in vitro but did not induce terminal differentiation of this cell line. In contrast to basal invasion, which was urokinase (uPA)- and plasmin-dependent, RA-enhanced invasion was dependent on tissue-type plasminogen activator (t-PA) and plasmin activity. Neither basal nor RA-enhanced invasion involved TIMP-2 inhibitable metalloproteinases. Enhanced invasion was associated with the induction of t-PA expression, increased expression of the putative t-PA receptor amphoterin, increased association of t-PA with cell membranes and increased net membrane-associated PA activity. Enhanced invasion was not associated with significant changes in the expression of uPA or its membrane receptor UPAR; plasminogen activator inhibitors PAI-1 and PAI-2; metalloproteinases MMP-1, MMP-2, MMP-3, MMP-9 and membrane type MMP1; or tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2. RA stimulated the association of t-PA with the external cell membrane surface, which could be inhibited by heparin sulphate but not by mannose sugars or chelators of divalent cations, consistent with a role for amphoterin. Our data indicate that RA can promote the malignant behavior of S-type neuroblastoma cells refractory to RA-mediated terminal differentiation by enhancing their basement membrane invasive capacity. We suggest that this results from the action of a novel, RA-regulated mechanism involving stimulation of t-PA expression and its association with the cell membrane leading to increased PA-dependent matrix degradation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Basement Membrane / drug effects
  • Basement Membrane / metabolism
  • Basement Membrane / pathology
  • Biocompatible Materials
  • Brain-Derived Neurotrophic Factor / metabolism
  • Cell Division / drug effects
  • Collagen
  • Drug Combinations
  • Humans
  • Laminin
  • Metalloendopeptidases / metabolism
  • Neoplasm Invasiveness
  • Neuroblastoma / metabolism
  • Neuroblastoma / pathology*
  • Phenotype
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Plasminogen Activator Inhibitor 2 / metabolism
  • Proteoglycans
  • Receptor Protein-Tyrosine Kinases / metabolism
  • Receptor, trkB
  • Receptors, Nerve Growth Factor / metabolism
  • Tissue Inhibitor of Metalloproteinases / metabolism
  • Tissue Plasminogen Activator / metabolism*
  • Tretinoin / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • Biocompatible Materials
  • Brain-Derived Neurotrophic Factor
  • Drug Combinations
  • Laminin
  • Plasminogen Activator Inhibitor 1
  • Plasminogen Activator Inhibitor 2
  • Proteoglycans
  • Receptors, Nerve Growth Factor
  • Tissue Inhibitor of Metalloproteinases
  • matrigel
  • Tretinoin
  • Collagen
  • Receptor Protein-Tyrosine Kinases
  • Receptor, trkB
  • Tissue Plasminogen Activator
  • Metalloendopeptidases